BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Gilead Sciences identifies new compounds for Zika virus infection
To read the full story,
subscribe
or
sign in
.
Infection
Gilead Sciences identifies new compounds for Zika virus infection
Dec. 13, 2022
No Comments
Gilead Sciences Inc. has presented pentacyclic derivative compounds reported to be useful for the treatment of Zika virus infection.
BioWorld Science
Infection
Patents